Acyclovir for treatment of postherpetic neuralgia: Efficacy and pharmacokinetics

Keyphrases

• Pharmacokinetics 100%
• Postherpetic Neuralgia 100%
• Acyclovir 100%
• Varicella Zoster Virus 50%
• Oral Acyclovir 50%
• Randomized Placebo-controlled Trial 25%
• Clinical Course 25%
• Shingles 25%
• Intravenous Administration 25%
• Oral Dosing 25%
• Antiviral Treatment 25%
• Immunocompromised Host 25%
• Time-varying Data 25%
• Severe Pain 25%
• Titer 25%
• Elimination Half-life 25%
• Time of Concentration 25%
• One-compartment 25%
• Two-compartment Model 25%
• Common Complications 25%
• Nerve Tissue 25%
• Young Individuals 25%
• Oral Clearance 25%
• Herpes Zoster 25%
• Terminal Half-life 25%
• Total Clearance 25%
• Humoral Antibody Response 25%
• Postherpetic Pain 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Pharmacokinetics 100%
• Aciclovir 100%
• Postherpetic Neuralgia 100%
• Herpes Zoster 40%
• Varicella Zoster Virus 40%
• Elimination 20%
• Placebo 20%
• Antivirus Agent 20%
• Disease Course 20%
• Humoral Antibody 20%

Immunology and Microbiology

• Pharmacokinetics 100%
• Varicella Zoster Virus 66%
• Herpes Zoster 66%
• Titer 33%
• Elimination Half-Life 33%
• Oral Clearance 33%
• Humoral Antibody 33%